Cyclo(Arg-Gly-Asp-D-Phe-Lys)

Product overview
Catalog Number
PPH08-0267
Sequence
cyclo (Arg-Gly-Asp-D-Phe-Lys)
Target
αvß3 Integrin Binding RGD Peptide RGD Tumor Targeting Peptide(Requires Further Derivatization Before Use), The Arg-Gly-Asp (RGD) sequence is a highly conserved integrin recognition sequence within fibronectin.
Description
An RGD tumor-targeting peptide, which binds to αvβ3 receptors. c(RGDfK) can be easily conjugated to fluorophore tags, chelators, or carriers. Palecek et al. converted the ε-amino group into the azide by diazo transfer allowing further functionalization by click chemistry. Mercapto groups can be introduced via acylation of c(RGDfK) with S-acetylthioacetic acid (SATA). C(RGDfK(Biotin-PEG-PEG)) where PEG = 8-Amino-3,6-Dioxaoctanoic Acid (M.W. 1120.30) C49H77N13O15S RGD Peptide equipped with a biotin reporting tag and PEG spacers for more efficient binding to lipid surfaces (Requires further derivatization before use)
Category
Catalog peptides, Biologically Active Peptides
Product Properties
Quantity

1mg, 5mg, 25mg
Storage

Shipped at 4°C. Store at -20°C for one year.
Purity

> 95%
Source

Synthetic
Forma appearance

Lyophilized powder
  • For research use only
  • Not for use in diagnostic procedures

€33,00 – €617,00 Tax excluded
Contact us to request price here
Register to buy peptides
Contact us